Company: MIRA
Filing Date: 2025-07-29
Form Type: PRER14A
Source: 0001641172-25-021434
Chunk: 17

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-29
Form: PRER14A
Chunk 17
---
 reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”), as described in the section titled “ The Merger—Material U.S. Federal Income

Tax Consequences of the Merger.”

The tax consequences to each SKNY stockholder will depend on that stockholder’s particular circumstances. Each SKNY stockholder should consult with his, her or its tax advisor for a full understanding of the tax consequences of the Merger to that stockholder.

Q: What do I need to do now?

A:MIRA and SKNY urge you to read this proxy statement carefully, including its annexes and information incorporated herein, and to consider how the Merger affects you.

If you are a holder of MIRA Common Stock as of the record date, please vote your shares as soon as possible so that your shares will be represented at the MIRA Annual Meeting. Please follow the instructions set forth on the enclosed proxy card or on the voting instruction form provided by the record holder of your shares if your shares are held in the name of your bank, broker or other nominee.

Q: Am I entitled to dissenters’ rights?

A:MIRA shareholders are not entitled to dissenters’ rights. See the section of this proxy statement titled “ Appraisal Rights and Dissenters’ Rights”on page 35.

Q: Am I entitled to appraisal rights?

A:MIRA shareholders are not entitled to appraisal rights. See the section of this proxy statement titled “ Appraisal Rights and Dissenters’ Rights”on page 35.

Q: Have SKNY’s stockholders agreed to adopt the Merger Agreement?

A:Yes. On June 9, 2025, SKNY’s stockholders adopted the Merger Agreement and approved the Merger and the other Contemplated Transactions via the SKNY Stockholder Written Consent (as defined below). For more information on the matters approved by the stockholders of SKNY please see the sections titled “ The Merger Agreement—Conditions to the Merger.”

Q: Who can help answer my questions?

A:If you are a holder of MIRA Common Stock as of the record date and would like additional copies, without charge, of this proxy statement or if you have questions about the Merger, including the procedures for voting your shares, you should contact MIRA at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida, (786) 432-9792.

| 5 |

<div